发明名称 |
Novel Galactoside Inhibitor of Galectins |
摘要 |
The present invention relates to a compound of the general formula (I): The compound of formula (I) is suitable for treating pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a mammal. Furthermore the present invention concerns a method of monitoring development or progression of pulmonary fibrosis in a human subject, a method of monitoring or predicting exacerbation of symptoms in a human subject with pulmonary fibrosis as well as a method for treatment of pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a human subject having a galectin-3 level indicative of pulmonary fibrosis or exacerbation of symptoms. |
申请公布号 |
US2014121179(A1) |
申请公布日期 |
2014.05.01 |
申请号 |
US201313832672 |
申请日期 |
2013.03.15 |
申请人 |
GALECTO BIOTECH AB;UNIVERSITY OF EDINBURGH |
发明人 |
HENDERSON NEIL;SETHI TARIQ;MACKINNON ALISON;LEFFLER HAKON;NILSSON ULF |
分类号 |
C07H19/056;A61M15/00;A61M16/14;G01N33/53 |
主分类号 |
C07H19/056 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|